Long-term remission of primary refractory ALK-positive anaplastic large cell lymphoma after allogeneic hematopoietic stem cell transplantation-Reference-Cited by-同舟云学术

Long-term remission of primary refractory ALK-positive anaplastic large cell lymphoma after allogeneic hematopoietic stem cell transplantation

Published:2022 Issue:3 Volume:62 Page:164-168
ISSN:1346-4280
Container-title:Journal of Clinical and Experimental Hematopathology
language:en
Short-container-title:J Clin Exp Hematopathol

Author:

Miyazaki Masahiro¹,Ichikawa Satoshi¹,Onishi Yasushi¹,Fukuhara Noriko¹,Furukawa Eijiro¹,Onodera Koichi¹,Yokoyama Hisayuki¹,Ichinohasama Ryo²,Harigae Hideo¹

Affiliation:

1. Department of Hematology, Tohoku University Hospital, Sendai, Japan,

2. Department of Hematopathology, Tohoku University Hospital, Sendai, Japan

Publisher

Japanese Society for Lymphoreticular Tissue Research

Subject

General Medicine

Link

https://www.jstage.jst.go.jp/article/jslrt/62/3/62_22003/_pdf

Reference21 articles.

1. 1 Ferreri AJM, Govi S, Pileri SA, Savage KJ. Anaplastic large cell lymphoma, ALK-positive. Crit Rev Oncol Hematol. 2012; 83: 293-302.

2. 2 Strullu M, Thomas C, Le Deley M-C et al. Hematopoietic stem cell transplantation in relapsed ALK+ anaplastic large cell lymphoma in children and adolescents: a study on behalf of the SFCE and SFGM-TC. Bone Marrow Transplant. 2015; 50: 795-801.

3. 3 Fukano R, Mori T, Kobayashi R et al. Haematopoietic stem cell transplantation for relapsed or refractory anaplastic large cell lymphoma: a study of children and adolescents in Japan. Br J Haematol. 2015; 168: 557-563.

4. 4 Miura Y, Fukuhara N, Yamamoto J et al. Clinicopathological features of malignant lymphoma in Japan: the Miyagi Study. Tohoku J Exp Med. 2011; 224: 151-160.

5. 5 Tsuyama N, Sakamoto K, Sakata S, Dobashi A, Takeuchi K. Anaplastic large cell lymphoma: pathology, genetics, and clinical aspects. J Clin Exp Hematop. 2017; 57: 120-142.